Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has shared an announcement.
Botanix Pharmaceuticals Limited has announced its Annual General Meeting scheduled for November 20, 2025, in Perth, Western Australia. Shareholders are encouraged to lodge their proxy forms online or via other specified methods before the meeting. This meeting is crucial for stakeholders as it provides an opportunity to discuss the company’s strategic direction and operational updates, potentially impacting future business decisions.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatology and antimicrobial products. The company is based in West Perth, Western Australia, and is involved in the research and commercialization of products for skin diseases and infections.
Average Trading Volume: 8,929,196
Technical Sentiment Signal: Sell
Current Market Cap: A$315.3M
See more data about BOT stock on TipRanks’ Stock Analysis page.